Valuation: Compumedics Limited

Market Cap 44.95M 31.55M 27.43M 25.53M 23.44M 44.26M 3.01B 301M 118M 1.5B 118M 116M 5.03B P/E 2026 *
15x
P/E 2027 * 6.08x
Enterprise Value 44.95M 31.55M 27.43M 25.53M 23.44M 44.26M 3.01B 301M 118M 1.5B 118M 116M 5.03B EV / Sales 2026 *
0.68x
EV / Sales 2027 * 0.56x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.89%
1 day+2.27%
1 week-2.17%
1 month-10.00%
3 months-20.35%
6 months-43.75%
Current year-32.84%
1 week 0.22
Extreme 0.215
0.24
1 month 0.22
Extreme 0.215
0.3
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%-2.17%-36.62%+36.36% 31.55M
-0.43%+1.06%+24.03%+3.71% 212B
-0.61%+1.82%-1.07%-24.39% 137B
+0.10%+4.69%-26.86%+12.57% 125B
+1.59%+5.60%-55.67%-7.68% 69.46B
-0.98%+4.16%+8.50%+7.08% 49.56B
+4.18%+7.79%-17.11%-20.97% 47.2B
-0.25%-0.14%+21.91%+8.35% 39.08B
-0.79%+0.70%+29.97%+29.32% 37.05B
+0.00%+5.67%+116.67%+8.20% 30.97B
Average +0.50%+2.87%+6.37%+5.25% 74.76B
Weighted average by Cap. +0.07%+2.80%+3.92%-0.66%

Financials

2026 *2027 *
Net sales 66.3M 46.54M 40.46M 37.66M 34.57M 65.29M 4.44B 444M 174M 2.21B 175M 171M 7.42B 79.7M 55.95M 48.63M 45.27M 41.56M 78.48M 5.34B 534M 209M 2.66B 210M 205M 8.92B
Net income 3.8M 2.67M 2.32M 2.16M 1.98M 3.74M 255M 25.44M 9.98M 127M 10.02M 9.8M 425M 9M 6.32M 5.49M 5.11M 4.69M 8.86M 603M 60.25M 23.65M 300M 23.73M 23.21M 1.01B
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
31/07/26 A$0.2250 +2.27% 5,811
29/07/26 A$0.2200 -8.33% 25,561
28/07/26 A$0.2400 -.--% 4,166
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2250AUD
Average target price
0.8000AUD
Spread / Average Target
+255.56%

Annual profits - Rate of surprise